Department of Neurosurgery, Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
Glia. 2011 Jun;59(6):927-35. doi: 10.1002/glia.21164. Epub 2011 Mar 28.
There is a critical relationship between oligodendrocyte development, myelin production, and iron bioavailability. Iron deficiency leads to hypomyelination both in humans and animal models, and the neurological sequelae of hypomyelination are significant. Therefore, understanding molecular mechanisms of iron import into oligodendrocytes is necessary for devising effective strategies for iron supplementation. Although transferrin has been considered as an essential component of oligodendrocyte media in culture, oligodendrocytes in vivo lack transferrin receptors. We have established that receptors for H-ferritin (HF) exist on cells of oligodendroglial lineage and that uptake of extracellular HF by oligodendrocyte progenitors is via receptor mediated endocytosis. These data strongly argue that ferritin is a major source of iron for oligodendrocytes. In this study, we demonstrate that media deficient in transferrin results in loss of viability of oligodendrocyte progenitors in culture. Cell loss could be prevented by supplementing the media with HF. Moreover, the addition of extracellular HF stimulates development of oligodendrocyte progenitor cells (OPCs) by increasing expression of myelin basic protein (MBP) and olig2 proteins without increasing their proliferation. The effect of HF on the OPCs could be mimicked by addition of membrane permeable 3,5,5-trimethylhexanoyl ferrocene (TMH-Fe) as an iron source to the media, but not membrane-impermeable ferric ammonium citrate. Overall, therefore, our results demonstrate the importance of iron for OPCs viability and differentiation and identify extracellular HF as a critical source of iron for oligodendrocytes. Given that ferritin receptors, but not transferrin receptors can be demonstrated on oligodendrocytes in vivo, the delivery of iron to oligodendrocytes via ferritin may be the more biological relevant delivery system.
少突胶质细胞的发育、髓鞘形成和铁的生物利用之间存在着关键关系。铁缺乏会导致人类和动物模型中的少突胶质细胞发育不全,而少突胶质细胞发育不全的神经学后果是显著的。因此,了解铁向少突胶质细胞内转运的分子机制对于设计有效的铁补充策略是必要的。尽管转铁蛋白已被认为是培养物中少突胶质细胞介质的重要组成部分,但体内少突胶质细胞缺乏转铁蛋白受体。我们已经证实,铁蛋白的 H 亚基(HF)受体存在于少突胶质细胞谱系的细胞上,而少突胶质细胞前体细胞对细胞外 HF 的摄取是通过受体介导的内吞作用进行的。这些数据强烈表明铁蛋白是少突胶质细胞铁的主要来源。在这项研究中,我们证明了缺乏转铁蛋白的培养基会导致培养中的少突胶质细胞前体细胞活力丧失。通过在培养基中添加 HF 可以防止细胞丢失。此外,添加细胞外 HF 通过增加少突胶质细胞前体细胞(OPC)髓鞘碱性蛋白(MBP)和 olig2 蛋白的表达来刺激其发育,而不会增加其增殖。HF 对 OPC 的作用可以通过向培养基中添加膜通透性 3,5,5-三甲基己酰基二茂铁(TMH-Fe)作为铁源来模拟,但不能通过膜不可渗透的柠檬酸铁铵来模拟。总的来说,我们的研究结果表明铁对 OPC 的活力和分化至关重要,并确定细胞外 HF 是少突胶质细胞铁的重要来源。鉴于体内的少突胶质细胞可以证明铁蛋白受体,但不能证明转铁蛋白受体,因此通过铁蛋白向少突胶质细胞输送铁可能是更具生物学相关性的输送系统。